ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-11V17534
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Site Directed Mutagenesis Services Market Research Report 2024
BUY CHAPTERS

Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11V17534
Report
November 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ACGT, Inc.
Azenta Life Sciences
Biocompare
NovoPro Bioscience Inc
Charles River
NZYTech
ThermoFisher
Epoch Life Science
Genewiz
GenScript
Creatve Biolabs
GeneToProtein

Gene Site-Directed Mutagenesis Services Market

The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Medical Industry accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Site-Directed Mutagenesis Services leading manufacturers including ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, etc., dominate supply; the top five capture approximately % of global revenue, with ACGT leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Site-Directed Mutagenesis Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Gene Site-Directed Mutagenesis Services Market Report

Report Metric Details
Report Name Gene Site-Directed Mutagenesis Services Market
Segment by Type
  • Synonymous Mutations
  • Missense Mutation
  • Nonsense Mutation
Segment by Application
  • Medical Industry
  • Biological Research
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, Genewiz, GenScript
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Gene Site-Directed Mutagenesis Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The main players in the Gene Site-Directed Mutagenesis Services Market are ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, Genewiz, GenScript

What are the Application segmentation covered in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The Applications covered in the Gene Site-Directed Mutagenesis Services Market report are Medical Industry, Biological Research, Others

What are the Type segmentation covered in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The Types covered in the Gene Site-Directed Mutagenesis Services Market report are Synonymous Mutations, Missense Mutation, Nonsense Mutation

1 Study Coverage
1.1 Introduction to Gene Site-Directed Mutagenesis Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Synonymous Mutations
1.2.3 Missense Mutation
1.2.4 Nonsense Mutation
1.3 Market Segmentation by Application
1.3.1 Global Gene Site-Directed Mutagenesis Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Biological Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Site-Directed Mutagenesis Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Site-Directed Mutagenesis Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Site-Directed Mutagenesis Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Site-Directed Mutagenesis Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Synonymous Mutations Market Size by Players
3.3.2 Missense Mutation Market Size by Players
3.3.3 Nonsense Mutation Market Size by Players
3.4 Global Gene Site-Directed Mutagenesis Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Site-Directed Mutagenesis Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Site-Directed Mutagenesis Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
6.4 North America Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Site-Directed Mutagenesis Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
7.4 Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Site-Directed Mutagenesis Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
9.4 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 ACGT
11.1.1 ACGT Corporation Information
11.1.2 ACGT Business Overview
11.1.3 ACGT Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.1.4 ACGT Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.1.5 ACGT Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.1.6 ACGT Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.1.7 ACGT Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.1.8 ACGT Gene Site-Directed Mutagenesis Services SWOT Analysis
11.1.9 ACGT Recent Developments
11.2 Azenta Life Sciences
11.2.1 Azenta Life Sciences Corporation Information
11.2.2 Azenta Life Sciences Business Overview
11.2.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.2.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.2.5 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.2.6 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.2.7 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.2.8 Azenta Life Sciences Gene Site-Directed Mutagenesis Services SWOT Analysis
11.2.9 Azenta Life Sciences Recent Developments
11.3 Biocompare
11.3.1 Biocompare Corporation Information
11.3.2 Biocompare Business Overview
11.3.3 Biocompare Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.3.4 Biocompare Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.3.5 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.3.6 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.3.7 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.3.8 Biocompare Gene Site-Directed Mutagenesis Services SWOT Analysis
11.3.9 Biocompare Recent Developments
11.4 NovoPro Bioscience Inc.
11.4.1 NovoPro Bioscience Inc. Corporation Information
11.4.2 NovoPro Bioscience Inc. Business Overview
11.4.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.4.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.4.5 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.4.6 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.4.7 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.4.8 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services SWOT Analysis
11.4.9 NovoPro Bioscience Inc. Recent Developments
11.5 Charles River
11.5.1 Charles River Corporation Information
11.5.2 Charles River Business Overview
11.5.3 Charles River Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.5.4 Charles River Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.5.5 Charles River Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.5.6 Charles River Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.5.7 Charles River Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.5.8 Charles River Gene Site-Directed Mutagenesis Services SWOT Analysis
11.5.9 Charles River Recent Developments
11.6 NZYtech
11.6.1 NZYtech Corporation Information
11.6.2 NZYtech Business Overview
11.6.3 NZYtech Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.6.4 NZYtech Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.6.5 NZYtech Recent Developments
11.7 Thermofisher
11.7.1 Thermofisher Corporation Information
11.7.2 Thermofisher Business Overview
11.7.3 Thermofisher Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.7.4 Thermofisher Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.7.5 Thermofisher Recent Developments
11.8 Creatve Biolabs
11.8.1 Creatve Biolabs Corporation Information
11.8.2 Creatve Biolabs Business Overview
11.8.3 Creatve Biolabs Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.8.4 Creatve Biolabs Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.8.5 Creatve Biolabs Recent Developments
11.9 Epoch Life Science
11.9.1 Epoch Life Science Corporation Information
11.9.2 Epoch Life Science Business Overview
11.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.9.5 Epoch Life Science Recent Developments
11.10 GeneToProtein
11.10.1 GeneToProtein Corporation Information
11.10.2 GeneToProtein Business Overview
11.10.3 GeneToProtein Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.10.4 GeneToProtein Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Genewiz
11.11.1 Genewiz Corporation Information
11.11.2 Genewiz Business Overview
11.11.3 Genewiz Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.11.4 Genewiz Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.11.5 Genewiz Recent Developments
11.12 GenScript
11.12.1 GenScript Corporation Information
11.12.2 GenScript Business Overview
11.12.3 GenScript Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.12.4 GenScript Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.12.5 GenScript Recent Developments
12 Gene Site-Directed Mutagenesis ServicesIndustry Chain Analysis
12.1 Gene Site-Directed Mutagenesis Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Site-Directed Mutagenesis Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Site-Directed Mutagenesis Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
ACGT, Inc.
Azenta Life Sciences
Biocompare
NovoPro Bioscience Inc
Charles River
NZYTech
ThermoFisher
Epoch Life Science
Genewiz
GenScript
Creatve Biolabs
GeneToProtein
List of Tables
 Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Gene Site-Directed Mutagenesis Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gene Site-Directed Mutagenesis Services Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Gene Site-Directed Mutagenesis Services Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Gene Site-Directed Mutagenesis Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2024)
 Table 11. Global Gene Site-Directed Mutagenesis Services Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Gene Site-Directed Mutagenesis Services Companies Headquarters
 Table 13. Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Gene Site-Directed Mutagenesis Services Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Gene Site-Directed Mutagenesis Services Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Gene Site-Directed Mutagenesis Services Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Gene Site-Directed Mutagenesis Services Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Gene Site-Directed Mutagenesis Services High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
 Table 25. North America Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
 Table 27. Europe Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Gene Site-Directed Mutagenesis Services Investment Opportunities and Key Challenges
 Table 31. Central and South America Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Gene Site-Directed Mutagenesis Services Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. ACGT Corporation Information
 Table 35. ACGT Description and Major Businesses
 Table 36. ACGT Product Features and Attributes
 Table 37. ACGT Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. ACGT Revenue Proportion by Product in 2024
 Table 39. ACGT Revenue Proportion by Application in 2024
 Table 40. ACGT Revenue Proportion by Geographic Area in 2024
 Table 41. ACGT Gene Site-Directed Mutagenesis Services SWOT Analysis
 Table 42. ACGT Recent Developments
 Table 43. Azenta Life Sciences Corporation Information
 Table 44. Azenta Life Sciences Description and Major Businesses
 Table 45. Azenta Life Sciences Product Features and Attributes
 Table 46. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Azenta Life Sciences Revenue Proportion by Product in 2024
 Table 48. Azenta Life Sciences Revenue Proportion by Application in 2024
 Table 49. Azenta Life Sciences Revenue Proportion by Geographic Area in 2024
 Table 50. Azenta Life Sciences Gene Site-Directed Mutagenesis Services SWOT Analysis
 Table 51. Azenta Life Sciences Recent Developments
 Table 52. Biocompare Corporation Information
 Table 53. Biocompare Description and Major Businesses
 Table 54. Biocompare Product Features and Attributes
 Table 55. Biocompare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Biocompare Revenue Proportion by Product in 2024
 Table 57. Biocompare Revenue Proportion by Application in 2024
 Table 58. Biocompare Revenue Proportion by Geographic Area in 2024
 Table 59. Biocompare Gene Site-Directed Mutagenesis Services SWOT Analysis
 Table 60. Biocompare Recent Developments
 Table 61. NovoPro Bioscience Inc. Corporation Information
 Table 62. NovoPro Bioscience Inc. Description and Major Businesses
 Table 63. NovoPro Bioscience Inc. Product Features and Attributes
 Table 64. NovoPro Bioscience Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. NovoPro Bioscience Inc. Revenue Proportion by Product in 2024
 Table 66. NovoPro Bioscience Inc. Revenue Proportion by Application in 2024
 Table 67. NovoPro Bioscience Inc. Revenue Proportion by Geographic Area in 2024
 Table 68. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services SWOT Analysis
 Table 69. NovoPro Bioscience Inc. Recent Developments
 Table 70. Charles River Corporation Information
 Table 71. Charles River Description and Major Businesses
 Table 72. Charles River Product Features and Attributes
 Table 73. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Charles River Revenue Proportion by Product in 2024
 Table 75. Charles River Revenue Proportion by Application in 2024
 Table 76. Charles River Revenue Proportion by Geographic Area in 2024
 Table 77. Charles River Gene Site-Directed Mutagenesis Services SWOT Analysis
 Table 78. Charles River Recent Developments
 Table 79. NZYtech Corporation Information
 Table 80. NZYtech Description and Major Businesses
 Table 81. NZYtech Product Features and Attributes
 Table 82. NZYtech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. NZYtech Recent Developments
 Table 84. Thermofisher Corporation Information
 Table 85. Thermofisher Description and Major Businesses
 Table 86. Thermofisher Product Features and Attributes
 Table 87. Thermofisher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Thermofisher Recent Developments
 Table 89. Creatve Biolabs Corporation Information
 Table 90. Creatve Biolabs Description and Major Businesses
 Table 91. Creatve Biolabs Product Features and Attributes
 Table 92. Creatve Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Creatve Biolabs Recent Developments
 Table 94. Epoch Life Science Corporation Information
 Table 95. Epoch Life Science Description and Major Businesses
 Table 96. Epoch Life Science Product Features and Attributes
 Table 97. Epoch Life Science Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Epoch Life Science Recent Developments
 Table 99. GeneToProtein Corporation Information
 Table 100. GeneToProtein Description and Major Businesses
 Table 101. GeneToProtein Product Features and Attributes
 Table 102. GeneToProtein Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. GeneToProtein Recent Developments
 Table 104. Genewiz Corporation Information
 Table 105. Genewiz Description and Major Businesses
 Table 106. Genewiz Product Features and Attributes
 Table 107. Genewiz Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Genewiz Recent Developments
 Table 109. GenScript Corporation Information
 Table 110. GenScript Description and Major Businesses
 Table 111. GenScript Product Features and Attributes
 Table 112. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. GenScript Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gene Site-Directed Mutagenesis Services Product Picture
 Figure 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Synonymous Mutations Product Picture
 Figure 4. Missense Mutation Product Picture
 Figure 5. Nonsense Mutation Product Picture
 Figure 6. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Medical Industry
 Figure 8. Biological Research
 Figure 9. Others
 Figure 10. Gene Site-Directed Mutagenesis Services Report Years Considered
 Figure 11. Global Gene Site-Directed Mutagenesis Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Gene Site-Directed Mutagenesis Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2020-2031)
 Figure 15. Global Gene Site-Directed Mutagenesis Services Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Synonymous Mutations Revenue Market Share by Player in 2024
 Figure 18. Missense Mutation Revenue Market Share by Player in 2024
 Figure 19. Nonsense Mutation Revenue Market Share by Player in 2024
 Figure 20. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2020-2031)
 Figure 21. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2020-2031)
 Figure 22. North America Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
 Figure 24. North America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
 Figure 31. Europe Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 34. France Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 46. India Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
 Figure 54. Central and South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
 Figure 60. South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
 Figure 66. Gene Site-Directed Mutagenesis Services Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Site directed Mutagenesis Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Mutagenesis Service Market Research Report 2024
Global Gene Service Market Research Report 2025
Global Gene Sequence Testing Service Market Research Report 2024
Global Gene Cloning Technology Services Market Research Report 2024
Site directed Mutagenesis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRISPR Gene Editing Service Market Research Report 2025
Global Fixed point Mutation Service Market Research Report 2024
Global Gene Cloning Service Market Research Report 2025
Global CRISPR Cas9 Gene Editing Service Market Research Report 2025
Global Clinical Grade Gene Test Service Market Research Report 2025
Global Gene Synthesis and Cloning Services Market Research Report 2024
Global Gene Subcloning Service Market Research Report 2025
Global Gene Synthesis Subcloning Service Market Research Report 2024
Site Directed Mutagenesis System Market
Global Genetically Modified Testing Service Market Research Report 2025
Global Consumer Grade Gene Test Service Market Research Report 2025
Global Tumor Gene Test Service Market Research Report 2025
Global Targeted Gene Sequencers Market Research Report 2024
Global Personal Gene Sequencing Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions